{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,27]],"date-time":"2026-08-27T04:45:22Z","timestamp":1787805922243,"version":"build-2784847793"},"reference-count":82,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"7","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Indian J Ophthalmol"],"published-print":{"date-parts":[[2018]]},"DOI":"10.4103\/ijo.ijo_1136_17","type":"journal-article","created":{"date-parts":[[2018,6,26]],"date-time":"2018-06-26T02:01:10Z","timestamp":1529978470000},"page":"896","source":"Crossref","is-referenced-by-count":45,"title":["Polypoidal choroidal vasculopathy: Pearls in diagnosis and management"],"prefix":"10.4103","volume":"66","author":[{"given":"Giridhar","family":"Anantharaman","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jay","family":"Sheth","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Muna","family":"Bhende","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raja","family":"Narayanan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sundaram","family":"Natarajan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anand","family":"Rajendran","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"George","family":"Manayath","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Parveen","family":"Sen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rupak","family":"Biswas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alay","family":"Banker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Charu","family":"Gupta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"key-10.4103\/0301-4738.234954-1","unstructured":"Yannuzzi LA. Idiopathic polypoidal choroidal vasculopathy. Macula Society Meeting. Miami, FL. 1982."},{"key":"key-10.4103\/0301-4738.234954-2","doi-asserted-by":"crossref","first-page":"1441","DOI":"10.1007\/s00417-007-0575-8","article-title":"Subtype lesions of neovascular age-related macular degeneration in chinese patients","author":"Liu","year":"2007","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"key":"key-10.4103\/0301-4738.234954-3","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.ajo.2007.03.047","article-title":"Clinical characteristics of exudative age-related macular degeneration in Japanese patients","author":"Maruko","year":"2007","journal-title":"Am J Ophthalmol"},{"key":"key-10.4103\/0301-4738.234954-4","doi-asserted-by":"crossref","first-page":"576","DOI":"10.3928\/15428877-20091030-07","article-title":"Polypoidal choroidal vasculopathy in Taiwanese patients","author":"Chang","year":"2009","journal-title":"Ophthalmic Surg Lasers Imaging"},{"key":"key-10.4103\/0301-4738.234954-5","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1007\/s10384-007-0498-2","article-title":"Incidence and clinical patterns of polypoidal choroidal vasculopathy in Korean patients","author":"Byeon","year":"2008","journal-title":"Jpn J Ophthalmol"},{"key":"key-10.4103\/0301-4738.234954-6","doi-asserted-by":"crossref","first-page":"752","DOI":"10.1007\/s004170000180","article-title":"Polypoidal choroidal vasculopathy in caucasians","author":"Lafaut","year":"2000","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"key":"key-10.4103\/0301-4738.234954-7","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1038\/sj.eye.6700706","article-title":"Polypoidal choroidal vasculopathy and exudative age-related macular degeneration in Greek population","author":"Ladas","year":"2004","journal-title":"Eye (Lond)"},{"key":"key-10.4103\/0301-4738.234954-8","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1097\/00006982-200104000-00004","article-title":"Polypoidal choroidal vasculopathy in Italy","author":"Scassellati-Sforzolini","year":"2001","journal-title":"Retina"},{"key":"key-10.4103\/0301-4738.234954-9","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1016\/j.survophthal.2010.03.004","article-title":"Polypoidal choroidal vasculopathy: A review","author":"Imamura","year":"2010","journal-title":"Surv Ophthalmol"},{"key":"key-10.4103\/0301-4738.234954-10","doi-asserted-by":"crossref","first-page":"1392","DOI":"10.1001\/archopht.121.10.1392","article-title":"Polypoidal choroidal vasculopathy: Incidence, demographic features, and clinical characteristics","author":"Sho","year":"2003","journal-title":"Arch Ophthalmol"},{"key":"key-10.4103\/0301-4738.234954-11","doi-asserted-by":"crossref","first-page":"399","DOI":"10.4103\/0301-4738.67052","article-title":"Clinical features, management and visual outcome of polypoidal choroidal vasculopathy in Indian patients","author":"Anantharaman","year":"2010","journal-title":"Indian J Ophthalmol","ISSN":"https:\/\/id.crossref.org\/issn\/0301-4738","issn-type":"print"},{"key":"key-10.4103\/0301-4738.234954-12","doi-asserted-by":"crossref","first-page":"686","DOI":"10.1097\/IAE.0b013e3182852446","article-title":"Polypoidal choroidal vasculopathy: Evidence-based guidelines for clinical diagnosis and treatment","author":"Koh","year":"2013","journal-title":"Retina"},{"key":"key-10.4103\/0301-4738.234954-13","unstructured":"Cheung G. Intravitreal Aflibercept in the Treatment of Polypoidal Choroidal Vasculopathy: The Planet Study. Presented at the 10th APVRS Annual Meeting, Bangkok; 2016."},{"key":"key-10.4103\/0301-4738.234954-14","doi-asserted-by":"crossref","first-page":"1206","DOI":"10.1001\/jamaophthalmol.2017.4030","article-title":"Efficacy and safety of ranibizumab with or without verteporfin photodynamic therapy for polypoidal choroidal vasculopathy: A Randomized clinical trial","author":"Koh","year":"2017","journal-title":"JAMA Ophthalmol"},{"key":"key-10.4103\/0301-4738.234954-15","first-page":"S51","article-title":"The fundoscopic features for differentiation between polypoidal choroidal vasculopathy and choroidal neovascularization from age-related macular degeneration","author":"Ampornpruet","year":"2005","journal-title":"J Med Assoc Thai"},{"key":"key-10.4103\/0301-4738.234954-16","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1016\/S0002-9394(02)01404-6","article-title":"Polypoidal choroidal vasculopathy: Natural history","author":"Uyama","year":"2002","journal-title":"Am J Ophthalmol"},{"key":"key-10.4103\/0301-4738.234954-17","doi-asserted-by":"crossref","first-page":"892","DOI":"10.1136\/bjo.86.8.892","article-title":"Polypoidal choroidal vasculopathy in Chinese patients","author":"Kwok","year":"2002","journal-title":"Br J Ophthalmol"},{"key":"key-10.4103\/0301-4738.234954-18","doi-asserted-by":"crossref","first-page":"910","DOI":"10.1016\/j.ajo.2011.10.017","article-title":"Peripheral exudative hemorrhagic chorioretinopathy: Polypoidal choroidal vasculopathy and hemodynamic modifications","author":"Mantel","year":"2012","journal-title":"Am J Ophthalmol"},{"key":"key-10.4103\/0301-4738.234954-19","doi-asserted-by":"crossref","first-page":"3187","DOI":"10.1167\/iovs.14-16236","article-title":"Toward a specific classification of polypoidal choroidal vasculopathy: Idiopathic disease or subtype of age-related macular degeneration","author":"Coscas","year":"2015","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"key-10.4103\/0301-4738.234954-20","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/S0039-6257(00)00123-5","article-title":"Fluorescence properties and metabolic features of indocyanine green (ICG) as related to angiography","author":"Desmettre","year":"2000","journal-title":"Surv Ophthalmol"},{"key":"key-10.4103\/0301-4738.234954-21","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1136\/bjophthalmol-2014-305674","article-title":"EVEREST study report 2: Imaging and grading protocol, and baseline characteristics of a randomised controlled trial of polypoidal choroidal vasculopathy","author":"Tan","year":"2015","journal-title":"Br J Ophthalmol"},{"key":"key-10.4103\/0301-4738.234954-22","doi-asserted-by":"crossref","first-page":"1375","DOI":"10.1097\/IAE.0000000000000482","article-title":"Improved specificity of polypoidal choroidal vasculopathy diagnosis using a modified Everest criteria","author":"Cheung","year":"2015","journal-title":"Retina"},{"key":"key-10.4103\/0301-4738.234954-23","first-page":"417","article-title":"Criteria for diagnosis of polypoidal choroidal vasculopathy","author":"Japanese","year":"2005","journal-title":"Nippon Ganka Gakkai Zasshi"},{"key":"key-10.4103\/0301-4738.234954-24","doi-asserted-by":"crossref","first-page":"1727","DOI":"10.1016\/S0161-6420(13)31433-X","article-title":"Digital indocyanine-green videoangiography of occult choroidal neovascularization","author":"Guyer","year":"1994","journal-title":"Ophthalmology"},{"key":"key-10.4103\/0301-4738.234954-25","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1136\/bjo.2008.145862","article-title":"Polypoidal choroidal vasculopathy and late geographic hyperfluorescence on indocyanine green angiography","author":"Kang","year":"2009","journal-title":"Br J Ophthalmol"},{"key":"key-10.4103\/0301-4738.234954-26","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1159\/000355488","article-title":"Polypoidal choroidal vasculopathy: Clinical features and genetic predisposition","author":"Honda","year":"2014","journal-title":"Ophthalmologica"},{"key":"key-10.4103\/0301-4738.234954-27","doi-asserted-by":"crossref","first-page":"1453","DOI":"10.1097\/IAE.0b013e31824f91e8","article-title":"EVEREST study: Efficacy and safety of verteporfin photodynamic therapy in combination with ranibizumab or alone versus ranibizumab monotherapy in patients with symptomatic macular polypoidal choroidal vasculopathy","author":"Koh","year":"2012","journal-title":"Retina"},{"key":"key-10.4103\/0301-4738.234954-28","doi-asserted-by":"crossref","first-page":"1576","DOI":"10.1016\/j.ophtha.2003.12.056","article-title":"Photodynamic therapy with verteporfin for symptomatic polypoidal choroidal vasculopathy: One-year results of a prospective case series","author":"Chan","year":"2004","journal-title":"Ophthalmology"},{"key":"key-10.4103\/0301-4738.234954-29","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1097\/IAE.0b013e31804b3f70","article-title":"Selective photodynamic therapy for neovascular age-related macular degeneration with polypoidal choroidal neovascularization","author":"Eandi","year":"2007","journal-title":"Retina"},{"key":"key-10.4103\/0301-4738.234954-30","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/j.ajo.2007.03.014","article-title":"Indocyanine green angiography: Guided photodynamic therapy for polypoidal choroidal vasculopathy","author":"Otani","year":"2007","journal-title":"Am J Ophthalmol"},{"key":"key-10.4103\/0301-4738.234954-31","doi-asserted-by":"crossref","first-page":"1421","DOI":"10.1007\/s00417-007-0564-y","article-title":"Angiographic lesion of polypoidal choroidal vasculopathy on indocyanine green and fluorescein angiography","author":"Gomi","year":"2007","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"key":"key-10.4103\/0301-4738.234954-32","doi-asserted-by":"crossref","first-page":"1528","DOI":"10.1136\/bjophthalmol-2014-305059","article-title":"A novel classification of the vascular patterns of polypoidal choroidal vasculopathy and its relation to clinical outcomes","author":"Tan","year":"2014","journal-title":"Br J Ophthalmol"},{"key":"key-10.4103\/0301-4738.234954-33","doi-asserted-by":"crossref","first-page":"1689","DOI":"10.2147\/OPTH.S68471","article-title":"Spectral-domain optical coherence tomography findings in polypoidal choroidal vasculopathy suggest a type 1 neovascular growth pattern","author":"Alshahrani","year":"2014","journal-title":"Clin Ophthalmol"},{"key":"key-10.4103\/0301-4738.234954-34","first-page":"1228","article-title":"Sensitivity and specificity of spectral-domain optical coherence tomography in detecting idiopathic polypoidal choroidal vasculopathy","author":"De","year":"2014","journal-title":"Am J Ophthalmol"},{"key":"key-10.4103\/0301-4738.234954-35","doi-asserted-by":"crossref","first-page":"778","DOI":"10.1097\/IAE.0000000000000794","article-title":"Distinguishing polypoidal choroidal vasculopathy from typical neovascular age-related macular degeneration based on spectral domain optical coherence tomography","author":"Liu","year":"2016","journal-title":"Retina"},{"key":"key-10.4103\/0301-4738.234954-36","doi-asserted-by":"crossref","first-page":"840","DOI":"10.1016\/j.ophtha.2010.09.012","article-title":"Choroidal thickness in polypoidal choroidal vasculopathy and exudative age-related macular degeneration","author":"Chung","year":"2011","journal-title":"Ophthalmology"},{"key":"key-10.4103\/0301-4738.234954-37","doi-asserted-by":"crossref","first-page":"3663","DOI":"10.1167\/iovs.12-9619","article-title":"Choroidal thickness, vascular hyperpermeability, and complement factor H in age-related macular degeneration and polypoidal choroidal vasculopathy","author":"Jirarattanasopa","year":"2012","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"key-10.4103\/0301-4738.234954-38","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1159\/000236040","article-title":"Clinical features of polypoidal choroidal vasculopathy and visual outcomes in the absence of classic choroidal neovascularization","author":"Yamaoka","year":"2010","journal-title":"Ophthalmologica"},{"key":"key-10.4103\/0301-4738.234954-39","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.preteyeres.2009.10.001","article-title":"Polypoidal choroidal vasculopathy and neovascular age-related macular degeneration: Same or different disease?","author":"Laude","year":"2010","journal-title":"Prog Retin Eye Res"},{"key":"key-10.4103\/0301-4738.234954-40","doi-asserted-by":"crossref","first-page":"1151","DOI":"10.1016\/j.ophtha.2013.12.037","article-title":"LAPTOP study: A 24-month trial of verteporfin versus ranibizumab for polypoidal choroidal vasculopathy","author":"Oishi","year":"2014","journal-title":"Ophthalmology"},{"key":"key-10.4103\/0301-4738.234954-41","doi-asserted-by":"crossref","first-page":"1569","DOI":"10.1097\/IAE.0000000000000526","article-title":"Initial versus delayed photodynamic therapy in combination with ranibizumab for treatment of polypoidal choroidal vasculopathy: The Fujisan Study","author":"Gomi","year":"2015","journal-title":"Retina"},{"key":"key-10.4103\/0301-4738.234954-42","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1097\/IAE.0b013e31816577cb","article-title":"Long-term results of photodynamic therapy of polypoidal choroidal vasculopathy","author":"Akaza","year":"2008","journal-title":"Retina"},{"key":"key-10.4103\/0301-4738.234954-43","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/j.ophtha.2007.02.031","article-title":"One-year outcomes of photodynamic therapy in age-related macular degeneration and polypoidal choroidal vasculopathy in Japanese patients","author":"Gomi","year":"2008","journal-title":"Ophthalmology"},{"key":"key-10.4103\/0301-4738.234954-44","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1159\/000221837","article-title":"Comparative assessment of photodynamic therapy for typical age-related macular degeneration and polypoidal choroidal vasculopathy: A multicenter study in Hyogo prefecture, Japan","author":"Honda","year":"2009","journal-title":"Ophthalmologica"},{"key":"key-10.4103\/0301-4738.234954-45","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1016\/j.ajo.2008.05.025","article-title":"Two-year results of photodynamic therapy for polypoidal choroidal vasculopathy","author":"Kurashige","year":"2008","journal-title":"Am J Ophthalmol"},{"key":"key-10.4103\/0301-4738.234954-46","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1007\/s10384-007-0501-y","article-title":"Photodynamic therapy for polypoidal choroidal vasculopathy: Vaso-occlusive effect on the branching vascular network and origin of recurrence","author":"Lee","year":"2008","journal-title":"Jpn J Ophthalmol"},{"key":"key-10.4103\/0301-4738.234954-47","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1177\/112067210601600506","article-title":"Photodynamic therapy with verteporfin in the treatment of exudative idiopathic polypoidal choroidal vasculopathy","author":"Mauget-Fa\u00ffsse","year":"2006","journal-title":"Eur J Ophthalmol"},{"key":"key-10.4103\/0301-4738.234954-48","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1007\/s10384-007-0436-3","article-title":"Photodynamic therapy for age-related macular degeneration in japanese patients: Results after one year","author":"Ogino","year":"2007","journal-title":"Jpn J Ophthalmol"},{"key":"key-10.4103\/0301-4738.234954-49","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1016\/S0002-9394(02)01516-7","article-title":"Exudative idiopathic polypoidal choroidal vasculopathy and photodynamic therapy with verteporfin","author":"Quaranta","year":"2002","journal-title":"Am J Ophthalmol"},{"key":"key-10.4103\/0301-4738.234954-50","doi-asserted-by":"crossref","first-page":"60","DOI":"10.3928\/1542-8877-20030101-14","article-title":"Photodynamic therapy of polypoidal choroidal vasculopathy","author":"Rogers","year":"2003","journal-title":"Ophthalmic Surg Lasers Imaging"},{"key":"key-10.4103\/0301-4738.234954-51","doi-asserted-by":"crossref","first-page":"1642","DOI":"10.1136\/bjo.2007.137075","article-title":"Photodynamic therapy with verteporfin for age-related macular degeneration or polypoidal choroidal vasculopathy: Comparison of the presence of serous retinal pigment epithelial detachment","author":"Saito","year":"2008","journal-title":"Br J Ophthalmol"},{"key":"key-10.4103\/0301-4738.234954-52","doi-asserted-by":"crossref","first-page":"1569","DOI":"10.1007\/s00417-007-0582-9","article-title":"Long-term follow-up of polypoidal choroidal vasculopathy after photodynamic therapy with verteporfin","author":"Sayanagi","year":"2007","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"key":"key-10.4103\/0301-4738.234954-53","doi-asserted-by":"crossref","first-page":"973","DOI":"10.1007\/s00417-005-1139-4","article-title":"Polypoidal choroidal vasculopathy and photodynamic therapy with verteporfin","author":"Silva","year":"2005","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"key":"key-10.4103\/0301-4738.234954-54","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1097\/00006982-200210000-00001","article-title":"Treatment of polypoidal choroidal vasculopathy with photodynamic therapy","author":"Spaide","year":"2002","journal-title":"Retina"},{"key":"key-10.4103\/0301-4738.234954-55","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1136\/bjo.2007.122283","article-title":"Efficacy of intravitreal bevacizumab for polypoidal choroidal vasculopathy","author":"Gomi","year":"2008","journal-title":"Br J Ophthalmol"},{"key":"key-10.4103\/0301-4738.234954-56","doi-asserted-by":"crossref","first-page":"1524","DOI":"10.1136\/bjo.2006.092783","article-title":"Different transitions of multifocal electroretinogram recordings between patients with age-related macular degeneration and polypoidal choroidal vasculopathy after photodynamic therapy","author":"Imai","year":"2006","journal-title":"Br J Ophthalmol"},{"key":"key-10.4103\/0301-4738.234954-57","doi-asserted-by":"crossref","first-page":"984","DOI":"10.1016\/j.ajo.2007.01.026","article-title":"Central retinal sensitivity measured with the micro perimeter 1 after photodynamic therapy for polypoidal choroidal vasculopathy","author":"Yodoi","year":"2007","journal-title":"Am J Ophthalmol"},{"key":"key-10.4103\/0301-4738.234954-58","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1097\/IAE.0000000000000767","article-title":"One-year results of intravitreal aflibercept for polypoidal choroidal vasculopathy","author":"Hara","year":"2016","journal-title":"Retina"},{"key":"key-10.4103\/0301-4738.234954-59","doi-asserted-by":"crossref","unstructured":"Videkar C, Kapoor A, Chhablani J, Narayanan R. Ziv-aflibercept: A novel option for the treatment of polypoidal choroidal vasculopathy. BMJ Case Rep 2015;2015. pii: bcr2015212988.","DOI":"10.1136\/bcr-2015-212988"},{"key":"key-10.4103\/0301-4738.234954-60","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/j.jcma.2013.10.012","article-title":"Comparison of the effect of reduced-fluence photodynamic therapy with intravitreal bevacizumab and standard-fluence alone for polypoidal choroidal vasculopathy","author":"Fan","year":"2014","journal-title":"J Chin Med Assoc"},{"key":"key-10.4103\/0301-4738.234954-61","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1007\/s10384-007-0452-3","article-title":"Role of photodynamic therapy in polypoidal choroidal vasculopathy","author":"Akaza","year":"2007","journal-title":"Jpn J Ophthalmol"},{"key":"key-10.4103\/0301-4738.234954-62","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1097\/01.iae.0000233647.78726.46","article-title":"Hemorrhagic complications after photodynamic therapy for polypoidal choroidal vasculopathy","author":"Hirami","year":"2007","journal-title":"Retina"},{"key":"key-10.4103\/0301-4738.234954-63","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1016\/j.ajo.2012.06.027","article-title":"Two-year results of reduced-fluence photodynamic therapy for polypoidal choroidal vasculopathy","author":"Yamashita","year":"2013","journal-title":"Am J Ophthalmol"},{"key":"key-10.4103\/0301-4738.234954-64","doi-asserted-by":"crossref","first-page":"947","DOI":"10.1016\/j.ajo.2009.12.038","article-title":"Combined photodynamic therapy with verteporfin and intravitreal bevacizumab for polypoidal choroidal vasculopathy","author":"Sato","year":"2010","journal-title":"Am J Ophthalmol"},{"key":"key-10.4103\/0301-4738.234954-65","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/j.ajo.2010.02.008","article-title":"Efficacy of intravitreal bevacizumab combined with photodynamic therapy for polypoidal choroidal vasculopathy","author":"Gomi","year":"2010","journal-title":"Am J Ophthalmol"},{"key":"key-10.4103\/0301-4738.234954-66","doi-asserted-by":"crossref","first-page":"1045","DOI":"10.1136\/bjo.2009.173120","article-title":"Photodynamic therapy combined with ranibizumab for polypoidal choroidal vasculopathy: Results of a 1-year preliminary study","author":"Ruamviboonsuk","year":"2010","journal-title":"Br J Ophthalmol"},{"key":"key-10.4103\/0301-4738.234954-67","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1167\/iovs.05-0354","article-title":"Influence of treatment parameters on selectivity of verteporfin therapy","author":"Michels","year":"2006","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"key-10.4103\/0301-4738.234954-68","doi-asserted-by":"crossref","first-page":"157","DOI":"10.3341\/kjo.2012.26.3.157","article-title":"Short-term effectiveness of intravitreal bevacizumab vs.ranibizumab injections for patients with polypoidal choroidal vasculopathy","author":"Cho","year":"2012","journal-title":"Korean J Ophthalmol"},{"key":"key-10.4103\/0301-4738.234954-69","doi-asserted-by":"crossref","first-page":"2178","DOI":"10.1097\/IAE.0000000000000229","article-title":"Short-term efficacy of intravitreal aflibercept in treatment-naive patients with polypoidal choroidal vasculopathy","author":"Inoue","year":"2014","journal-title":"Retina"},{"key":"key-10.4103\/0301-4738.234954-70","doi-asserted-by":"crossref","first-page":"1866","DOI":"10.1016\/j.ophtha.2015.05.024","article-title":"One-year results of intravitreal aflibercept for polypoidal choroidal vasculopathy","author":"Yamamoto","year":"2015","journal-title":"Ophthalmology"},{"key":"key-10.4103\/0301-4738.234954-71","doi-asserted-by":"crossref","first-page":"2192","DOI":"10.1097\/IAE.0000000000000236","article-title":"Switching to intravitreal aflibercept injection for polypoidal choroidal vasculopathy refractory to ranibizumab","author":"Saito","year":"2014","journal-title":"Retina"},{"key":"key-10.4103\/0301-4738.234954-72","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1097\/01.iae.0000249386.63482.05","article-title":"Tomographic features of branching vascular networks in polypoidal choroidal vasculopathy","author":"Sato","year":"2007","journal-title":"Retina"},{"key":"key-10.4103\/0301-4738.234954-73","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1016\/j.ajo.2009.09.020","article-title":"One-year results of reduced-fluence photodynamic therapy for polypoidal choroidal vasculopathy","author":"Yamashita","year":"2010","journal-title":"Am J Ophthalmol"},{"key":"key-10.4103\/0301-4738.234954-74","doi-asserted-by":"crossref","first-page":"1020","DOI":"10.1038\/eye.2011.110","article-title":"Characteristics of fine vascular network pattern associated with recurrence of polypoidal choroidal vasculopathy","author":"Oishi","year":"2011","journal-title":"Eye (Lond)"},{"key":"key-10.4103\/0301-4738.234954-75","doi-asserted-by":"crossref","first-page":"936","DOI":"10.1136\/bjo.2007.132357","article-title":"Marked vascular changes of polypoidal choroidal vasculopathy after photodynamic therapy","author":"Wakabayashi","year":"2008","journal-title":"Br J Ophthalmol"},{"key":"key-10.4103\/0301-4738.234954-76","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1016\/j.ajo.2010.05.026","article-title":"Improvement of angiographic findings of polypoidal choroidal vasculopathy after intravitreal injection of ranibizumab monthly for 3 months","author":"Hikichi","year":"2010","journal-title":"Am J Ophthalmol"},{"key":"key-10.4103\/0301-4738.234954-77","doi-asserted-by":"crossref","first-page":"226","DOI":"10.3341\/kjo.2015.29.4.226","article-title":"Aflibercept treatment for neovascular age-related macular degeneration and polypoidal choroidal vasculopathy refractory to anti-vascular endothelial growth factor","author":"Moon","year":"2015","journal-title":"Korean J Ophthalmol"},{"key":"key-10.4103\/0301-4738.234954-78","doi-asserted-by":"crossref","first-page":"1427","DOI":"10.1038\/eye.2015.150","article-title":"High-dose ranibizumab monotherapy for neovascular polypoidal choroidal vasculopathy in a predominantly non-asian population","author":"Marcus","year":"2015","journal-title":"Eye (Lond)"},{"key":"key-10.4103\/0301-4738.234954-79","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1016\/j.ajo.2012.08.002","article-title":"Argon laser with and without anti-vascular endothelial growth factor therapy for extrafoveal polypoidal choroidal vasculopathy","author":"Gemmy","year":"2013","journal-title":"Am J Ophthalmol"},{"key":"key-10.4103\/0301-4738.234954-80","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1038\/sj.eye.6702955","article-title":"Argon laser photocoagulationfor the treatment of polypoidal choroidal vasculopathy","author":"Lee","year":"2009","journal-title":"Eye (Lond)"},{"key":"key-10.4103\/0301-4738.234954-81","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1016\/S0021-5155(03)00042-X","article-title":"A study of laser photocoagulation for polypoidal choroidal vasculopathy","author":"Yuzawa","year":"2003","journal-title":"Jpn J Ophthalmol"},{"key":"key-10.4103\/0301-4738.234954-82","doi-asserted-by":"crossref","first-page":"770","DOI":"10.1016\/S0002-9394(03)01147-4","article-title":"Laser photocoagulation of indocyanine green angiographically identified feeder vessels to idiopathic polypoidal choroidal vasculopathy","author":"Nishijima","year":"2004","journal-title":"Am J Ophthalmol"}],"container-title":["Indian Journal of Ophthalmology"],"original-title":[],"language":"en","deposited":{"date-parts":[[2026,8,14]],"date-time":"2026-08-14T13:33:05Z","timestamp":1786714385000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.4103\/ijo.IJO_1136_17"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018]]},"references-count":82,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2018]]}},"alternative-id":["234954"],"URL":"https:\/\/doi.org\/10.4103\/ijo.ijo_1136_17","relation":{},"ISSN":["0301-4738"],"issn-type":[{"value":"0301-4738","type":"print"}],"subject":[],"published":{"date-parts":[[2018]]}}}